{"id":"W2114421863","doi":"10.1016/s0168-8278(10)60033-5","title":"31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS","year":2010,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"BioPhage Pharma (Canada); University of Ottawa; University of Manitoba; University of British Columbia","funders":"","keywords":"Virology; Genotype; Nucleoside analogue; Medicine; Antiviral treatment; Polymerase; Nucleoside; Biology; Virus; Chronic hepatitis; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003982661,0.0001374551,0.0004450141,0.0001548059,0.0001850648,0.0004088058,0.0001159621,0.0003003118,0.0009743483],"category_scores_gemma":[0.001252146,0.0001030474,0.0002949639,0.0001229831,0.0001791909,0.0002523289,0.00007018945,0.0004841644,0.0001912795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002745711,"about_ca_system_score_gemma":0.0002393717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006339064,"about_ca_topic_score_gemma":0.0008564513,"domain_scores_codex":[0.999765,0.0001052709,0.0000214272,0.00002876218,0.00004083009,0.00003866122],"domain_scores_gemma":[0.9995528,0.0001809949,0.0001344354,0.00002820484,0.00002958391,0.00007401442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1521888,0.003772754,0.5563846,0.0004904153,0.000801398,0.002612169,0.0007446973,0.001962604,0.110181,0.0004945521,0.001240297,0.1691267],"study_design_scores_gemma":[0.004254944,0.1078118,0.8654206,0.00006067749,0.0006782894,0.003076462,0.0003018532,0.002314491,0.0131043,0.0002745384,0.002645091,0.00005688695],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984514,0.0008465115,0.00002826898,0.00003951499,0.000007017598,0.00000766848,0.00006689419,0.000003492962,0.0005491964],"genre_scores_gemma":[0.9994117,0.0001991734,0.00002152969,0.00004487382,0.00001421981,0.000003140069,0.00009879018,0.000001094189,0.000205499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009743483,"threshold_uncertainty_score":0.00325954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003860461092103142,"score_gpt":0.211352978017188,"score_spread":0.2074925169250848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}